Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1046 (LINC01046) is a long non-coding RNA (lncRNA) gene that encodes a transcript over 200 nucleotides in length and does not overlap with annotated protein-coding genes[1][3][7]. LINC01046 belongs to the subclass of long intergenic non-coding RNAs (lincRNAs), which are known to modulate gene expression by mechanisms including chromatin remodeling, transcriptional regulation, and RNA stabilization, often showing tissue-specific expression patterns[3][7]. While many lincRNAs have described roles in regulating key cellular processes and have been implicated in disease (including cancer), there is currently no direct evidence in available databases or literature indicating that LINC01046 itself is a clinically actionable therapeutic target, nor are there established drugs, biomarker roles, or associated safety concerns[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1046 (LINC01046).